Skip to content

The effect of Arnotts Vita-Weat supplementation on weight loss in overweight and obese participants.

A randomised controlled trial to determine the efficacy of Vita-Weat food supplementation on weight loss in overweight and obese participants.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614001283662
Enrollment
76
Registered
2014-12-09
Start date
2015-01-05
Completion date
2015-04-06
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

An area of research that receives a lot of attention currently relates to the physiological mechanisms that are involved in maintaining the feeling of fullness after people have eaten (referred to as satiety). Previous studies have shown that the most satisfying foods were found to be high in carbohydrate or protein, and most were also high in water and fibre. Considering the high carbohydrate (> 60 grams per 100 grams) and high protein (>10 grams per 100 grams) content of Campbell Arnotts Vita-Weat range, these products may produce greater satiety and hence help produce weight loss for those needing to lose weight. The current randomised controlled trial is designed to investigate the beneficial effect of this food product in an overweight and obese population group.

Interventions

During the six week intervention period, the intervention group will replace their breakfast and lunch each day with either 2 Arnott's Lunch Slices or up to 6 Vita-Weat crispbreads based on personal preference, with a choice of prescribed toppings consisting of a protein, vegetable and condiment component. An Accredited Practising Dietitian will administer the intervention during a one on one, face to face consultation of approximately 30 minutes duration. To aid with dietary compliance, parti

During the six week intervention period, the intervention group will replace their breakfast and lunch each day with either 2 Arnott's Lunch Slices or up to 6 Vita-Weat crispbreads based on personal preference, with a choice of prescribed toppings consisting of a protein, vegetable and condiment component. An Accredited Practising Dietitian will administer the intervention during a one on one, face to face consultation of approximately 30 minutes duration. To aid with dietary compliance, participants will be required to complete and return a 3 day diet diary (2 working days and 1 weekend day) at the first (Baseline) and final (Week 6) visits. Participants will receive enough product for the duration of the study.

Sponsors

University of Sydney
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
25 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

*Aged 25-55 years *Pre-menopausal *BMI greater than or equal to 25 to less than or equal to 35 kg /m^2 *Regular eating habits; familiar with Vita-Weat

Exclusion criteria

*Type 1 diabetes *Type 2 diabetes treated with insulin *Coeliac disease and gluten intolerance *Previous bariatric surgery *Untreated thyroid disease *Greater than 10% change in body weight over the past 3 months *Alcohol or illicit drug abuse *Pregnant or breastfeeding women, and women who might be planning pregnancy during the duration of the study *Use of weight loss medications and other drugs that may affect body weight e.g. anti-psychotics, anti-depressants, or corticosteroids *A history or presence of malignancy [completely resected basal or squamous cell carcinoma of the skin if treatment completed > 6 months prior to enrolment and participants in remission for > 5 years prior to screening remain eligible] *Inability to read and write English *A history of frequently changing smoking habits, in addition to smoking cessation within 6 months prior to screening. Those who wish to take on the advice of a 'Quit' smoking programme at the time of screening will be eligible to start the trial after 6 months *Participants may also be excluded, if in the opinion of the study investigators, they have some other condition or disorder that may adversely affect the outcome of the study or the safety of the participant

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026